AVXL: Anavex Life Sciences Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 835.43
Enterprise Value ($M) 703.25
Book Value ($M) 120.26
Book Value / Share 1.42
Price / Book 6.95
NCAV ($M) 120.26
NCAV / Share 1.42
Price / NCAV 6.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.36
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 8.86
Current Ratio 8.86

Balance Sheet (mrq) ($M)
Current Assets 135.57
Assets 135.57
Liabilities 15.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -50.59
Net Income -43.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.81
Cash from Investing 0.00
Cash from Financing 11.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 5.31 5.22
01-25 13G/A BlackRock, Inc. 8.10 19.59
2024-01-22 13G/A State Street Corp 4.44 -37.33

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 309,690 1,029,667 30.08
2025-01-21 268,603 1,386,662 19.37
2025-01-17 589,372 2,761,422 21.34

(click for more detail)

Similar Companies
ATHA – Athira Pharma, Inc. ATRA – Atara Biotherapeutics, Inc.
AVIR – Atea Pharmaceuticals, Inc. BBIO – BridgeBio Pharma, Inc.
BCRX – BioCryst Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Anavex Life Sciences